(Q44054382)

29 November 2017

title

Membrane heme as a host factor in reducing effectiveness of dihydroartemisinin (English)

1 reference

29 November 2017

author name string

Phantip Vattanaviboon

1

1 reference

29 November 2017

Noppadol Siritanaratkul

2

1 reference

29 November 2017

Jidapa Ketpirune

3

1 reference

29 November 2017

Prapon Wilairat

4

1 reference

29 November 2017

Yongyuth Yuthavong

5

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

29 November 2017

published in

Biochemical Pharmacology

1 reference

29 November 2017

volume

64

1 reference

29 November 2017

issue

1

1 reference

29 November 2017

page(s)

91-98

1 reference

Malaria: new developments in treatment and prevention

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901060-2

Artemisinin drugs: novel antimalarial agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901060-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901060-2

Artemisinin drugs in the treatment of malaria: from medicinal herb to registered medication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901060-2

Artemisinin: current status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901060-2

Resistance to artemisinin of malaria parasites (Plasmodium falciparum) infecting alpha-thalassemic erythrocytes in vitro. Competition in drug accumulation with uninfected erythrocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901060-2

Inactivation of artemisinin by thalassemic erythrocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901060-2

Binding of dihydroartemisinin to hemoglobin H: role in drug accumulation and host-induced antimalarial ineffectiveness of alpha-thalassemic erythrocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901060-2

Thalassemia: pathophysiology of red cell changes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901060-2

Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901060-2

Decreased sensitivity of artesunate and chloroquine of Plasmodium falciparum infecting hemoglobin H and/or hemoglobin constant spring erythrocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901060-2

Kinetics of the interaction of hemin liposomes with heme binding proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901060-2

Possible modes of action of the artemisinin-type compounds.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901060-2

Influence of hemoglobin E trait on the antimalarial effect of artemisinin derivatives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901060-2

Decreased growth of Plasmodium falciparum in red cells containing haemoglobin E, a role for oxidative stress, and a sero-epidemiological correlation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901060-2

Increased phagocytosis of Plasmodium falciparum-infected erythrocytes with haemoglobin E by peripheral blood monocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901060-2

Effects of alpha-thalassemia on pharmacokinetics of the antimalarial agent artesunate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901060-2

10.1016/S0006-2952(02)01060-2

7 January 2021

Identifiers

DOI

1 reference

29 November 2017

1 reference